Double Bond Pharmaceutical International AB (publ) - ESG Rating & Company Profile powered by AI
The webpage includes a questions and answers table for Double Bond Pharmaceutical International AB (publ). This webpage is a free E,S&G analysis for Double Bond Pharmaceutical International AB (publ). This assessment of Double Bond Pharmaceutical International AB (publ) leverages data points from across the web as well as from available disclosures by Double Bond Pharmaceutical International AB (publ).
Double Bond Pharmaceutical International AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.8; made up of an environmental score of 0.0, social score of 0.0 and governance score of 5.3.
1.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1617 | Berry Genomics Co Ltd | 1.9 | Low |
1617 | scPharmaceuticals Inc | 1.9 | Low |
1631 | Double Bond Pharmaceutical International AB (publ) | 1.8 | Low |
1631 | Cannabis Global, Inc. | 1.8 | Low |
1631 | Cannabis Strategic Ventures | 1.8 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Double Bond Pharmaceutical International AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Does Double Bond Pharmaceutical International AB (publ) disclose current and historical energy intensity?
Does Double Bond Pharmaceutical International AB (publ) report the average age of the workforce?
Does Double Bond Pharmaceutical International AB (publ) reference operational or capital allocation in relation to climate change?
Does Double Bond Pharmaceutical International AB (publ) disclose its ethnicity pay gap?
Does Double Bond Pharmaceutical International AB (publ) disclose cybersecurity risks?
Does Double Bond Pharmaceutical International AB (publ) offer flexible work?
Does Double Bond Pharmaceutical International AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Double Bond Pharmaceutical International AB (publ) disclose the number of employees in R&D functions?
Does Double Bond Pharmaceutical International AB (publ) conduct supply chain audits?
Does Double Bond Pharmaceutical International AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Double Bond Pharmaceutical International AB (publ) conduct 360 degree staff reviews?
Does Double Bond Pharmaceutical International AB (publ) disclose the individual responsible for D&I?
Does Double Bond Pharmaceutical International AB (publ) disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Double Bond Pharmaceutical International AB (publ) disclose current and / or historical scope 2 emissions?
Does Double Bond Pharmaceutical International AB (publ) disclose water use targets?
Does Double Bond Pharmaceutical International AB (publ) have careers partnerships with academic institutions?
Did Double Bond Pharmaceutical International AB (publ) have a product recall in the last two years?
Does Double Bond Pharmaceutical International AB (publ) disclose incidents of discrimination?
Does Double Bond Pharmaceutical International AB (publ) allow for Work Councils/Collective Agreements to be formed?
Has Double Bond Pharmaceutical International AB (publ) issued a profit warning in the past 24 months?
Does Double Bond Pharmaceutical International AB (publ) disclose parental leave metrics?
Does Double Bond Pharmaceutical International AB (publ) disclose climate scenario or pathway analysis?
Does Double Bond Pharmaceutical International AB (publ) disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Double Bond Pharmaceutical International AB (publ) disclose the pay ratio of women to men?
Does Double Bond Pharmaceutical International AB (publ) support suppliers with sustainability related research and development?
Does Double Bond Pharmaceutical International AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Double Bond Pharmaceutical International AB (publ) reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Double Bond Pharmaceutical International AB (publ) involved in embryonic stem cell research?
Does Double Bond Pharmaceutical International AB (publ) disclose GHG and Air Emissions intensity?
Does Double Bond Pharmaceutical International AB (publ) disclose its waste policy?
Does Double Bond Pharmaceutical International AB (publ) report according to TCFD requirements?
Does Double Bond Pharmaceutical International AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Double Bond Pharmaceutical International AB (publ) disclose energy use targets?
Does Double Bond Pharmaceutical International AB (publ) disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Double Bond Pharmaceutical International AB (publ) have a policy relating to cyber security?
Have a different question?
Potential Risks for Double Bond Pharmaceutical International AB (publ)
These potential risks are based on the size, segment and geographies of the company.